Loading clinical trials...
Loading clinical trials...
Phase 1 Study of CART-BCMA With or Without huCART19 as Consolidation of Standard First or Second-Line Therapy for High-Risk Multiple Myeloma
Conditions
Interventions
BCMA CART + huCART19
CART BCMA or CART BCMA + huCART19
+2 more
Locations
1
United States
Univ. of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
May 9, 2018
Primary Completion Date
March 1, 2036
Completion Date
March 1, 2036
Last Updated
June 26, 2025
NCT07249528
NCT06215118
NCT06679101
NCT05969860
NCT06057402
NCT06383143
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions